Your browser doesn't support javascript.
COVID-19 Management Missteps.
Boudi, F Brian; Patel, Sabin; Patel, Kajal; Parikh, Kajal; Patel, Neha; Boudi, Max; Patel, Samir; Patel, Himanshu.
  • Boudi FB; Cardiology, University of Arizona College of Medicine, Phoenix, USA.
  • Patel S; Biology, Baylor University, Waco, USA.
  • Patel K; Biology, Emory University, Atlanta, USA.
  • Parikh K; Biological Sciences, Rutgers University, New Brunswick, USA.
  • Patel N; Psychology, University of Alabama at Birmingham, Birmingham, USA.
  • Boudi M; Education, Arizona State University, Phoenix, USA.
  • Patel S; Biomedical Engineering, Arizona State University, Phoenix, USA.
  • Patel H; Psychiatry, University of Arizona College of Medicine, Phoenix, USA.
Cureus ; 14(3): e23059, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: covidwho-1766147
ABSTRACT
In December 2019, the first case of a novel coronavirus infectious disease, coronavirus disease 2019 (COVID-19), was identified in the province of Wuhan, China. Since the initial identification on March 11, 2020, by the World Health Organization (WHO), COVID-19 had rapidly spread all over the world, leading to the declaration of COVID-19 as a pandemic. In response to the exponential trend of reported confirmed cases, national governments worked quickly to devise plans to combat the spread and to soften the consequences which were to follow. Two primary approaches included limiting the spread of the virus and increasing hospital capacity. The implementation of these strategies, however, varied greatly among different governments and their respective populations. Countries developed similar guidelines in response to COVID-19, but with a variation. Many of these guidelines were similar in that they fell under the same general topics such as the use of facial masks, social distancing, and online learning. The effect of COVID-19 on public health was more reliant on the implementation of these recommendations rather than the recommendations themselves.  The medical therapies used to treat the widespread COVID-19 disease are flourishing and evolving rapidly. Ongoing research shows that the spectrum of treatment for COVID-19 varies from pharmacological and non-pharmacological therapeutic interventions. Some of the treatments that are being used in clinical practice include supportive care, antiviral drugs, immunomodulatory agents, convalescent plasma transfusion, and monoclonal antibody treatments. In addition, the most promising approach thus far is the COVID-19 vaccine developed by Pfizer-BioNTech, Moderna, and most recently Johnson & Johnson. Overall, as various treatment approaches are being explored and administered to people globally, it is important to acknowledge that there is currently no definite cure or any evidence-based treatment for COVID-19.  COVID-19 infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have brought devastating consequences to the lives of millions of people through their health effects and the failure of global initiatives to contain it. A review of many missteps that potentially could have altered the landscape for this virus to affect the lives of many is discussed with hope for a better approach going forward.
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Tipo de estudo: Estudo prognóstico Tópicos: Vacinas Idioma: Inglês Revista: Cureus Ano de publicação: 2022 Tipo de documento: Artigo País de afiliação: Cureus.23059

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Tipo de estudo: Estudo prognóstico Tópicos: Vacinas Idioma: Inglês Revista: Cureus Ano de publicação: 2022 Tipo de documento: Artigo País de afiliação: Cureus.23059